Basel Medical Group Ltd (BMGL)

Basel Medical Group Statistics

Total Valuation

BMGL has a market cap or net worth of $26.49 million. The enterprise value is $22.48 million.

Market Cap	26.49M
Enterprise Value	22.48M

Important Dates

The last earnings date was Tuesday, November 4, 2025, before market open.

Earnings Date	Nov 4, 2025
Ex-Dividend Date	n/a

Share Statistics

BMGL has 18.79 million shares outstanding.

Current Share Class	18.79M
Shares Outstanding	18.79M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	13.65%
Owned by Institutions (%)	0.82%
Float	6.05M

Valuation Ratios

The trailing PE ratio is 72.86.

PE Ratio	72.86
Forward PE	n/a
PS Ratio	3.12
Forward PS	n/a
PB Ratio	4.31
P/TBV Ratio	4.98
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	71.50
EV / Sales	3.06
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.74.

Current Ratio	1.88
Quick Ratio	1.60
Debt / Equity	0.74
Debt / EBITDA	17.43
Debt / FCF	n/a
Interest Coverage	-1.09

Financial Efficiency

Return on equity (ROE) is 6.10% and return on invested capital (ROIC) is -1.45%.

Return on Equity (ROE)	6.10%
Return on Assets (ROA)	-1.21%
Return on Invested Capital (ROIC)	-1.45%
Return on Capital Employed (ROCE)	-4.21%
Revenue Per Employee	$229,452
Profits Per Employee	$9,828
Employee Count	32
Asset Turnover	0.63
Inventory Turnover	68.63

Taxes

Income Tax	-204,678
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	1.72
200-Day Moving Average	n/a
Relative Strength Index (RSI)	37.86
Average Volume (20 Days)	61,469

Short Selling Information

The latest short interest is 252,279, so 1.34% of the outstanding shares have been sold short.

Short Interest	252,279
Short Previous Month	380,977
Short % of Shares Out	1.34%
Short % of Float	4.17%
Short Ratio (days to cover)	0.03

Income Statement

In the last 12 months, BMGL had revenue of $7.34 million and earned $314,485 in profits. Earnings per share was $0.02.

Revenue	7.34M
Gross Profit	2.07M
Operating Income	-223,994
Pretax Income	109,807
Net Income	314,485
EBITDA	-198,501
EBIT	-223,994
Earnings Per Share (EPS)	$0.02

Balance Sheet

The company has $7.96 million in cash and $3.95 million in debt, giving a net cash position of $4.00 million or $0.21 per share.

Cash & Cash Equivalents	7.96M
Total Debt	3.95M
Net Cash	4.00M
Net Cash Per Share	$0.21
Equity (Book Value)	5.32M
Book Value Per Share	0.33
Working Capital	4.97M

Cash Flow

In the last 12 months, operating cash flow was -$1.04 million and capital expenditures -$13,451, giving a free cash flow of -$1.11 million.

Operating Cash Flow	-1.04M
Capital Expenditures	-13,451
Free Cash Flow	-1.11M
FCF Per Share	-$0.06

Margins

Gross margin is 28.24%, with operating and profit margins of -3.05% and 4.28%.

Gross Margin	28.24%
Operating Margin	-3.05%
Pretax Margin	1.50%
Profit Margin	4.28%
EBITDA Margin	-2.70%
EBIT Margin	-3.05%
FCF Margin	n/a

Dividends & Yields

BMGL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	1.19%
FCF Yield	-4.19%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BMGL has an Altman Z-Score of 1.83 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.83
Piotroski F-Score	1